Sep 3, 2026

Featuring perspectives from Dr Lisa A Carey and Dr Maha Hussain, including the following topics:

• Introduction (0:00)
• HER2 History (1:32)
• Cases from the GMO Survey (7:06)
• Biology and Selection of First-Line Therapy for HR-Positive, HER2-Positive Metastatic Breast Cancer (mBC) — Dr Mahtani (19:56)
• Faculty Case...

Sep 2, 2026

Featuring perspectives from Dr William G Wierda, including the following topics:

• Introduction: Overview of the Grand Rounds Chronic Lymphocytic Leukemia Initiative (0:00)
• Sequencing Road Map (12:39)
• Key Datasets — Pirtobrutinib (21:08)
• Investigator Survey (34:09)
• Chimeric Antigen Receptor T-Cell Therapy (45:08)
• Other...

Sep 1, 2026

Description: Featuring a slide presentation and related discussion from Prof Ticiana Leal, including the following topics:

·      Incidence, pathophysiology and clinical presentation (0:00)

·      Diagnostic challenges and evaluation process (3:37)

·      Treatment modalities and therapeutic options (10:01)

·

Sep 1, 2026

Featuring an interview with Prof Ticiana Leal, including the following topics:

• Pathophysiology and clinical signs and symptoms (0:00)
• Screening and/or diagnostic approaches (5:45)
• Potential impact of available therapies for small cell lung cancer (SCLC) on paraneoplastic syndromes (7:36)
• Key clinical trial data for...

Aug 31, 2026

Featuring perspectives from Mr Michael Lai, Dr Scott T Tagawa, Ms Stacy E Walker and Dr Evan Y Yu, moderated by Dr Tagawa, including the following topics:

• Introduction (0:00)
• Overview of Prostate Cancer (3:00)
• Hormonal Therapy for Nonmetastatic and Metastatic Hormone-Sensitive Prostate Cancer (HSPC) (6:12)
• Potential...